168 related articles for article (PubMed ID: 16024624)
1. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
2. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
3. CaSm: an Sm-like protein that contributes to the transformed state in cancer cells.
Schweinfest CW; Graber MW; Chapman JM; Papas TS; Baron PL; Watson DK
Cancer Res; 1997 Jul; 57(14):2961-5. PubMed ID: 9230209
[TBL] [Abstract][Full Text] [Related]
4. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer.
Kelley JR; Fraser MM; Hubbard JM; Watson DK; Cole DJ
Anticancer Res; 2003; 23(3A):2007-13. PubMed ID: 12894573
[TBL] [Abstract][Full Text] [Related]
5. The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer.
Kelley JR; Brown JM; Frasier MM; Baron PL; Schweinfest CW; Vournakis JN; Watson DK; Cole DJ
Surgery; 2000 Aug; 128(2):353-60. PubMed ID: 10923016
[TBL] [Abstract][Full Text] [Related]
6. Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma.
Yan Y; Rubinchik S; Watson PM; Kelley JR; Fraser MM; Wood AL; Dong JY; Gillanders WE; Boylan AM; Watson DK; Cole DJ
Mol Ther; 2005 Mar; 11(3):363-72. PubMed ID: 15727932
[TBL] [Abstract][Full Text] [Related]
7. Reversion of human prostate tumorigenic growth by azatyrosine.
Benoit RM; Eiseman J; Jacobs SC; Kyprianou N
Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512
[TBL] [Abstract][Full Text] [Related]
8. Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer.
Yan Y; Rubinchik S; Wood AL; Gillanders WE; Dong JY; Watson DK; Cole DJ
Mol Ther; 2006 Feb; 13(2):357-65. PubMed ID: 16226492
[TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
[TBL] [Abstract][Full Text] [Related]
11. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
12. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
13. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
[TBL] [Abstract][Full Text] [Related]
14. CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes.
Watson PM; Miller SW; Fraig M; Cole DJ; Watson DK; Boylan AM
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):671-8. PubMed ID: 18218995
[TBL] [Abstract][Full Text] [Related]
15. A role for the WWOX gene in prostate cancer.
Qin HR; Iliopoulos D; Semba S; Fabbri M; Druck T; Volinia S; Croce CM; Morrison CD; Klein RD; Huebner K
Cancer Res; 2006 Jul; 66(13):6477-81. PubMed ID: 16818616
[TBL] [Abstract][Full Text] [Related]
16. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
Shain SA
Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
[TBL] [Abstract][Full Text] [Related]
17. Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line.
Ma L; Gauvillé C; Berthois Y; Millot G; Johnson GR; Calvo F
Oncogene; 1999 Nov; 18(47):6513-20. PubMed ID: 10597254
[TBL] [Abstract][Full Text] [Related]
18. EphB4 expression and biological significance in prostate cancer.
Xia G; Kumar SR; Masood R; Zhu S; Reddy R; Krasnoperov V; Quinn DI; Henshall SM; Sutherland RL; Pinski JK; Daneshmand S; Buscarini M; Stein JP; Zhong C; Broek D; Roy-Burman P; Gill PS
Cancer Res; 2005 Jun; 65(11):4623-32. PubMed ID: 15930280
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
[TBL] [Abstract][Full Text] [Related]
20. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]